The crude ethanol extract of Pulsatilla chinensis (Bunge) Regel roots was extracted successively with light petroleum, dichloromethane and n-butanol. The light petroleum fraction (PEF) exhibited potent anti-proliferation activity on HL60 cells with an IC 50 value of 14 μg/mL. As a result, ICR mice transplanted with tumor strain S180 were employed for testing the effectiveness of drug administration of PEF. The tumor inhibitory rate was 36.7% at a dose of 20 mg/kg/d, which was higher than the positive control, which produced 31.5% inhibition. However, an unusual phenomenon was observed in that the tumor inhibitory response was reverse dose-dependent since tumor inhibition was only 19.5% at a dose of 180 mg/kg/d. GC-MS revealed that the main components of the PEF were C-19 and C-22 polyunsaturated fatty acids. Previous studies had revealed that polyunsaturated fatty acids exhibit either anti-tumor or tumor promoting activities, and so it is proposed that the effects of PEF on tumor growth is dependent on dosage.
Ranunculaceae, which is listed in the Chinese Pharmacopeia, has been used to remove heat, expel miasma and cool the blood to stop diarrhea [1] . It has also been used for the treatment of amoebic dysentery and malaria. Triterpenoid saponins are the main components [2] . The essential oil was analyzed by GC-MS; the major component was alkane. In previous studies, the anti-tumor activity of the ethanol and water extracts of the roots was investigated [3] . A study was also conducted to observe the preventive and therapeutic effect of an extract from P. chinensis roots on a mice colorectal cancer model induced by dimethylhydrazine. The extract of P. chinensis has also been shown to enhance the immunological function and have an anti-inflammatory effect.
The significant anti-tumor activity of the extracts was considered worthy of further study. Previous studies had focused on the anti-tumor activity of the crude ethanol and water extracts, but the components that showed the most potent anti-tumor activity were unknown. To find the most active fraction, the ethanol extract was extracted with light petroleum, dichloromethane and n-butanol. These fractions were then tested against a human promyelocytic leukemia cell line (HL60).
The anti-tumor activities of the light petroleum (PEF), dichloromethane and n-butanol fractions were evaluated in vitro against HL-60 cells, and showed dose dependent results (Figure1). The PEF showed significant inhibition of HL60 cells; the highest inhibitory rate was 92.4% at a concentration of 50 μg/mL, which was close to the positive control, platinol (4 μg/mL), for which the inhibitory rate was 92.2%, and the IC 50 value 14 μg/mL The dichloromethane fraction showed a stable dosedependent increase in inhibitory rate and reached the highest rate of 85.7% when at 100 μg/mL, with an IC 50 of 27 μg/mL. However, the n-butanol fraction showed low anti-tumor activity, with an IC 50 value of 88 μg/mL. DMSO was used as a negative control. The in vitro data suggested that the light petroleum fraction exhibited an anti-proliferative effect on HL60 cells. In order to find out if this fraction were able to suppress tumor growth in vivo, ICR mice transplanted with tumor strain S180 were employed. Following one week of drug administration, the tumor weight was significantly diminished. The average tumor weight (ATW) of the control group was 0.84 g and of the CTX (30 mg/kg/2d) -treated mice 0.58 g, with a tumor inhibitory rate (TIR) of 31.4%. However, the 20 mg/kg fraction group showed a better anti-tumor activity than CTX, for which the ATW was 0.53 g and the TIR was 36.7% (Table 1) . There was an inverse dose-dependent phenomenon: the 60 mg/kg fraction group showed a weaker activity than the 20 mg/kg fraction group with an ATW of 0.58 g and a TIR of 30.9%, which was approximately the same as those of the CTX group. The highest dose group (180 mg/kg) showed the worst activity with an ATW of 0.68 g and a TIR of 19.5%, but these were still significantly As potent anti-tumor activity had been shown by the PEF, an in vivo study was undertaken, which exhibited anti-tumor activity against ICR mice transplanted with a S180 tumor strain. However, an interesting phenomenon was seen in that the low dose group exhibited better anti-tumor properties than the high dose group. The group given a dose of 20 mg/kg produced a significant anti-tumor activity, better than the positive control CTX, but when the dose increased, the anti-tumor activity decreased, showing that the PEF only exhibited potent activity at low doses. This indicated that the active compounds showed inverse activities when the dose increased. Anti-inflammatory activity of n-3PUFA has been recorded, but the mechanism is still uncertain. Possible mechanisms of the n-3 and n-6 PUFAs on inflammation were described relative to either the production of reactive oxygen species or being through a p38 mitogen activated protein kinase pathway [4] . As cyclooxygenase (COX-2) was believed to be inducible and involved in inflammatory responses, studies on the role of n-3 and n-6 fatty acids in the modulation of COX-2 expression in vivo and in vitro were undertaken, and revealed that n-3 and n-6 fatty acids induced COX-2 expression in various cancer cell lines, as well as in animal models [5] , and in human keratinocyte HaCaT cells via PPARγ activation [6] .
Previous studies indicated that PUFA exhibited the potential for preventing cancer, and the fatty acid ethyl ester derivatives could induce apoptosis in HepG2 cells [7] . Further study of fatty acids against cancer found opposing effects of n-6 and n-3 PUFA in the prevention of non-melanoma skin cancer [8] . Also, the n-3 FA dramatically reduced the plasma and cutaneous pro-inflammatory and immunosuppressive PGE 2 levels in mice, while the n-6 FA increased the PGE 2 level [9] . The mechanism for the opposite effect of PUFAs in promoting carcinogenesis was that linoleic acid can be first converted to arachidonic acid and in turn to prostaglandins (PGs) by cyclooxygenases (COX-2).
PGs are known to increase cell proliferation, promote angiogenesis, and inhibit immune surveillance, all of which were favorable for the growth of tumor cells [10] . Later, the PUFAs were shown to induce COX-2 expression in inflammation, but they could be either protective or deleterious according to the balance between the pro-inflammatory and anti-inflammatory effects of prostanoids produced by various cell types under different circumstances [11] . So, the inverse dose-dependent activity of PEF may be related to the opposing effects of the PUFAs; when the dosage is low, the main action, including cytotoxicity of PUFAs, is antitumor, but when the dosage is increased, the reverse effects promote angiogenesis and increase cell proliferation, which lead to the decease of tumor inhibition.
In conclusion, the present study indicates that the PEF of P. chinensis exhibits potent anti-tumor activity both in vivo and in vitro, and C-19 and C-21 fatty acids were recognized as the active compounds.
Further study is still needed to reveal the relationship between dosage of PUFA and antitumor activity. The PEF components still need to be further investigated.
Experimental
General: The analysis of compounds was performed on an Agilent 6890N GC/MS system (Agilent Technologies, Waldbronn, Germany). Silica gel (300-400 mesh) was employed for CC, while chromatographic fractions were monitored through TLC (GF254), with detection by TLC UV analysis Video System (Yokozs, Wuhan New Technique Company Ltd., Wuhan, China ) at 254 and 365 nm, and by color reaction after spraying with a solution of H 2 SO 4 /EtOH (1:9), followed by 5 min heating at ca.100ºC. The colorimetric assays were performed with a Microplate reader (EL×800, BIO-TEK Instruments. Inc., USA). Bruker Biospin AMX 400 was used for NMR measurements.
Plant materials:
The roots of P. chinensis were collected in Liaoning Province, People's Republic of China, in January, 2007. The plant material was identified by the authors, and a voucher specimen (PCR070115) has been deposited in the herbarium of the IPI of Zhejiang University.
Extraction:
The dried roots (3 kg) were extracted 3 times with 95% ethanol, each for 3 h at 85 o C. The extract was concentrated to dryness to give a brown residue, which was suspended in distilled water (2 L) and then partitioned with light petroleum (3×2 L), CH 2 Cl 2 (3×2 L) and n-BuOH (3×2 L), successively; 4 fractions were obtained. The light petroleum fraction weighed approx. 20 g, the CH 2 Cl 2 fraction approx. 60 g, the n-BuOH fraction approx. 150 g, and the water fraction approx. 150 g.
Cell culture:
The human acute myeloid leukemia cell line HL-60 was maintained in RPMI-1640 medium (Gibco BRL) with 3.7 g/L sodium bicarbonate, supplemented with 10% heat-inactivated fetal bovine serum (FBS). The cultures were maintained at 37 o C. The reference drug was platinol, used at a final concentration of 4 μg/mL. All the above cell lines, purchased from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China), were seeded in 96-well tissue culture plates, and maintained in a humidified atmosphere of 5% CO 2 and 95% air at 37 o C for 3-6 days before experimentation.
Dose-response analysis:
The light petroleum, CH 2 Cl 2 and n-BuOH fractions were transferred to overnight cells. Non-treated cells were used as control. Cells were cultured overnight and were then subjected to colorimetric assay. IC 50 was calculated as the dose at which 50% cell death occurred relative to the untreated cells.
Colorimetric assay:
In the colorimetric assay for HL-60, cell growth was evaluated by determining the IC 50 using a modification of the sulforhodamine B (SRB; Sigma, MI, USA) assay. Briefly, after removing the medium, the cultures (per well) were fixed to the plastic substratum by gently adding 70 µL of 40% trichloroacetic acid (TCA) in 0.9% NaCl solution. The cultures were incubated for 1 h at 4 o C and then washed 5 times with water to remove the redundant TCA. After drying, 100 µl 0.4% SRB was added to each well for staining. The plates were placed in the dark for 20 min, then quickly rinsed five times with 1.0% acetic acid to remove unbound dye. The cultures were air-dried and the bound dye was solubilized with 150 µL of 10 mmol/L unbuffered Tris base (Ph 10.5). After agitation for 5 min at 700 rpm, the absorbance was read at 490 nm using a microplate reader.
Animal experiment:
The experiment was carried out on 8-weeks old male ICR mice, with an average weight of about 20 g. The mice were killed by cervical dislocation just 1 week after tumor strain S180 had been transplanted through intraperitoneal injection, then soaked in 0.1% bromogeramine for 5 min, and placed on an ice plate. The ascites were drawn and diluted with three-fold physiological saline, then the dilution (0.2 mL per mouse) was inoculated subcutaneously. The inoculated mice were randomly assigned to the control and treatment group with 10 mice in each group. The mice were housed individually per cage and kept for at least 5 days prior to the start of the study. They were maintained at about 27 o C, with a 12 h alternate light and dark cycle. The mice were given an unlimited supply of standard diet and water. The treatment group was given the PEF at three doses of 20, 60, 180 mg/kg BW, while the control group received Cyclophosphamid (CTX), 30mg/kg/2d, as reference drug. The solvent for dissolution of the extract and CTX was Tween 80 and distilled water. Both groups were administered orally using an intubation needle delivered in a 2 mL volume per day. The animals were observed systematically after the administration and daily thereafter for 8 days. Body weight was monitored at the same time of day every 2 days throughout the test period. The mice were killed by cervical dislocation just 24 h after the last administration, and weighed. The tumor mass was sliced and weighed immediately; the tumor control rate was calculated by the equation below:
Average tumor weight of control group-Average tumor weight of treatment group Tumor control rate= 100% Average tumor weight of treatment group × Identification by GC/MS: A volume of 100 μL of the fraction (oil) was diluted to 500 μL with n-hexane and injected into the GC-MS. A ZB-5MS column (30 m in length, 0.25 mm i.d., and 0.25 μm thickness) was used and the carrier gas was helium. The oven temperature was maintained initially at 160 o C for 5 min, then was programmed at a rate of 5 o C/min up to a final temperature 300 o C with an isotherm for 10 min. The injector and detector temperatures were set at 300 and 280 o C, respectively. The PEF components were identified by comparing their retention times and mass fragmentation patterns with those of standards and the MS library (NIST2002 MS Library).
Statistical analyses:
The difference in cell antiproliferation and S180 tumor strain assay were compared using the Student's test. P<0.05 was considered as significant.
